Stamford Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 1
- Market Cap
- -
To Assess the Safety and Efficacy of SP-002 With Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Stamford Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT06344052
- Locations
- 🇺🇸
Research Site, Longview, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath